Downregulation of miR-1231 and miR-188–3p increased GPX4 expression and intracellular GSH levels, thereby suppressing ferroptosis and promoting progression in papillary thyroid cancer and osteosarcoma, respectively [131,132]. Here, GPX4 is linked to osteosarcoma.